These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8647008

  • 1. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
    Kietzmann M, Meyer-Lindenberg A, Engelke A, Nolte I.
    Dtsch Tierarztl Wochenschr; 1996 Jan; 103(1):14-6. PubMed ID: 8647008
    [Abstract] [Full Text] [Related]

  • 2. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
    Scherkl R, Hashem A, Frey HH.
    Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
    [Abstract] [Full Text] [Related]

  • 3. Plasma and tissue kinetics of phenylbutazone and naproxen in dogs.
    Zech R, Scherkl R, Hashem A, Frey HH.
    Arch Int Pharmacodyn Ther; 1993 May; 325():113-28. PubMed ID: 8110026
    [Abstract] [Full Text] [Related]

  • 4. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H, Hashem A.
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [Abstract] [Full Text] [Related]

  • 5. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD, Sams RA, Harris ON, Ashcraft SM.
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL, Matthews NS, Peck KE, Ray AC, Taylor TS.
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M, Lees P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K.
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses.
    Navarre CB, Ravis WR, Nagilla R, Simpkins A, Duran SH, Pugh DG.
    J Vet Pharmacol Ther; 2001 Jun; 24(3):227-31. PubMed ID: 11442803
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E, Bianchi C, Gaetani M, Pozzi L.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.